TERMINATION - Dismissing the Proceeding | Aug 3, 2017 | PAPER | BOARD |
Joint Motion to Terminate | Aug 1, 2017 | PAPER | PETITIONER |
Confidential Exhibit | Aug 1, 2017 | EXHIBIT | PETITIONER |
Joint Request to Make Confidential | Aug 1, 2017 | PAPER | PETITIONER |
Patent Owner's Sur-Reply re Paper 14 | Jun 16, 2017 | PAPER | PATENT OWNER |
Petitioner Reply to Patent Owner Preliminary Response | Jun 9, 2017 | PAPER | PETITIONER |
Conduct of the Proceeding
37 C.F.R. sec 42.5 | Jun 2, 2017 | PAPER | BOARD |
Patent Owner's Mandatory Change-of-Information Notices | Jun 2, 2017 | PAPER | PATENT OWNER |
EX2001 Sessler Declaration | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2002 Sessler CV | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2006 Order | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2007 Complaint | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2011 Customer Outage Notification | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2012 Business Wire | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2013 Erratum | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2014 Bioniche Press Release | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2016 Orange Book | May 8, 2017 | EXHIBIT | PATENT OWNER |
REDACTED EX2003 Dansky Declaration | May 8, 2017 | EXHIBIT | PATENT OWNER |
PROTECTIVE ORDER MATERIAL - EX2003 Dansky Declaration | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2004 Dansky CV | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2005 R&R | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2008 Order to Show Cause | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2009 Order | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2010 Lyphazurin Drug Release | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2015 Mylan Acquisition Press Release | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2020 Hirsch 1989 | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2023 Grygar | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2025 How Does HPLC Work | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2026 Bucher | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2029 Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2030 Aurobindo Overview | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2017 Kerns | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2018 Rao | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2019 PBV Sigma Listing | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2021 Waters Website Search | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2022 PBV Calcium Salt Sigma Listing | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2024 CRC | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2027 Mylan Form 10K 2015 | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2028 Isosulfan Blue for Injection | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2031 Aurobindo 2014-15 Annual Report | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2032 Aurobindo 2015-16 Annual Report | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2036 Isosulfan Blue Application Acceptance | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2038 IMS Health | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2033 Aurobindo USA About Us | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2034 Sentinel Lymph Node Mapping | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2035 Sentinel Lymph Node Biopsy - National Cancer Institute | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2037 Amended Texas Complaint | May 8, 2017 | EXHIBIT | PATENT OWNER |
PROTECTIVE ORDER MATERIAL - EX2040 IMS Data thru March 2016 | May 8, 2017 | EXHIBIT | PATENT OWNER |
PROTECTIVE ORDER MATERIAL - EX2041 IMS Data thru July 2016 | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2042 Mylan_ISB_Sell_Sheet_RL_4-11-2017 | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2039 Quintile Sims | May 8, 2017 | EXHIBIT | PATENT OWNER |
EX2043 Stipulated Protective Order | May 8, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Seal | May 8, 2017 | PAPER | PATENT OWNER |
Patent Owner's Preliminary Response | May 8, 2017 | PAPER | PATENT OWNER |
Mandatory Notices | Feb 14, 2017 | PAPER | PATENT OWNER |
Apicore US LLC's Power of Attorney | Feb 14, 2017 | PAPER | PATENT OWNER |
Mylan Institutional LLC's Power of Attorney | Feb 14, 2017 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Feb 7, 2017 | PAPER | BOARD |
Power of Attorney | Jan 24, 2017 | PAPER | PETITIONER |
File history for US patent application No. 12/643,056 | Jan 24, 2017 | EXHIBIT | PETITIONER |
File history for US patent application No. 11/747,291 | Jan 24, 2017 | EXHIBIT | PETITIONER |
Douglas S. Reintgen, M.D. CV | Jan 24, 2017 | EXHIBIT | PETITIONER |
Pasquale N. Confalone, Ph.D. Declaration | Jan 24, 2017 | EXHIBIT | PETITIONER |
Hiranaka et al., "Chemical structure and purity of dyes used
in lymphograms," American Journal of Hospital
Pharmacy 32(9):928-30 (October 1975) | Jan 24, 2017 | EXHIBIT | PETITIONER |
Hirsch et al., "Use of Isosulfan Blue for Identification of
Lymphatic Vessels: Experimental and Clinical Evaluation,"
Am. J. of Roentgenology 139: 1061-64 (1982) | Jan 24, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,659,053 | Jan 24, 2017 | EXHIBIT | PETITIONER |
Adrian G. Dan et al., "1% Lymphazurin vs 10% Fluorescein
for sentinel node mapping in colorectal tumors" (Arch.
Surg. 139:1180-84 (2004)) | Jan 24, 2017 | EXHIBIT | PETITIONER |
Mark D. Argentine et al., "Strategies for the investigation
and control of process-related impurities in drug substances"
(Advanced Drug Delivery Reviews 59:12-28 (2007)) | Jan 24, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,573,752 | Jan 24, 2017 | EXHIBIT | PETITIONER |
PCT Patent Application Publication No. WO2005/009423A1 | Jan 24, 2017 | EXHIBIT | PETITIONER |
Isosulfan Blue Prescribing Information (Mylan Institutional LLC) | Jan 24, 2017 | EXHIBIT | PETITIONER |
Product specific recommendations for generic drug development | Jan 24, 2017 | EXHIBIT | PETITIONER |
Printout from http://isosulfanblue.mylan.com/ | Jan 24, 2017 | EXHIBIT | PETITIONER |
Printout from http://isosulfanblue.mylan.com/en/safety | Jan 24, 2017 | EXHIBIT | PETITIONER |
PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 9,353,050 | Jan 24, 2017 | PAPER | PETITIONER |
U.S. Patent No. 9,353,050 | Jan 24, 2017 | EXHIBIT | PETITIONER |
File history for US patent application No. 13/310,019 | Jan 24, 2017 | EXHIBIT | PETITIONER |
File history for US patent application No. 12/180,057 | Jan 24, 2017 | EXHIBIT | PETITIONER |
Douglas S. Reintgen, M.D. Declaration | Jan 24, 2017 | EXHIBIT | PETITIONER |
Cox et al., "Guidelines for Sentinel Node Biopsy and
Lymphatic Mapping of Patients With Breast Cancer," Annals
of Surgery 5:645-653 (1998) | Jan 24, 2017 | EXHIBIT | PETITIONER |
Pasquale N. Confalone, Ph.D. CV | Jan 24, 2017 | EXHIBIT | PETITIONER |
U.S. Patent Application Publication No. 2006/0224003 | Jan 24, 2017 | EXHIBIT | PETITIONER |
Peter J. Lee & Alice J. Di Gioia, "Acquity UPLC
Separation of Triarylmethane Ink Dyes (Part 1)" (June
2005) | Jan 24, 2017 | EXHIBIT | PETITIONER |
Huber and Majors, "Principles in preparative HPLC"
Agilent Technologies, Pub. No. 5989-0652EN, March
2004 | Jan 24, 2017 | EXHIBIT | PETITIONER |
Snyder et al.,"Preparative HPLC Separation" in Practical
HPLC Method Development (John Wiley & Sons, Inc. 2nd
ed. 1997) | Jan 24, 2017 | EXHIBIT | PETITIONER |
Newton et al., "Physiochemical Characteristics of Patent
Blue Violet Dye," J. of Pharmaceutical Sciences Vol. 70,
No. 2, 122-127 (February 1981) | Jan 24, 2017 | EXHIBIT | PETITIONER |
Declaration of Phyllis Bell and D. Thoraval et al.,
"Development of Paper, Chemical Agent Detector, 3-Way,
Liquid Containing Non-Mutagenic Dyes" (1988) | Jan 24, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 2,726,252 | Jan 24, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 1,531,507 | Jan 24, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 4,045,458 | Jan 24, 2017 | EXHIBIT | PETITIONER |
PCT Patent Application Publication No. WO 2004/092122A2 | Jan 24, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,207,660 | Jan 24, 2017 | EXHIBIT | PETITIONER |
Reintgen et al., "Breast Lymphatic Mapping and Sentinel
Lymph Node Biopsy: State of the Art: 2015," Clinical
Breast Cancer Vol. 16, No. 3, 155-65 (June 2016) | Jan 24, 2017 | EXHIBIT | PETITIONER |
Lymphazurin Prescribing Information (United States Surgical Corp.) | Jan 24, 2017 | EXHIBIT | PETITIONER |
FDA notice for Lymphazurin | Jan 24, 2017 | EXHIBIT | PETITIONER |
Printout from http://isosulfanblue.mylan.com/en/efficacy | Jan 24, 2017 | EXHIBIT | PETITIONER |
Q3d Elemental Impurities, Guidance for Industry (Sept.
2015) | Jan 24, 2017 | EXHIBIT | PETITIONER |
"The Chemistry of Leuco Triarylmethanes" in Chemistry
and Applications of Leuco Dyes (Plenum Press 1997) | Jan 24, 2017 | EXHIBIT | PETITIONER |
Martin et al., "Theoretical and Experimental Study of
Recycling in High-Performance Liquid Chromatography," J.
of Chromatography Vol. 125, 17-41 (1976) | Jan 24, 2017 | EXHIBIT | PETITIONER |
Peter J. Lee & Alice J. Di Gioia, "Acquity UPLC One
Minute Separation of Triarylmethane Dyes and Colorant of
Ball Point Pen Inks" (Poster presented during August 28-
September 1, 2005 ACS National Meeting) | Jan 24, 2017 | EXHIBIT | PETITIONER |
"Triphenylmethane and Related Dyes" in Van Nostrand's
Scientific Encyclopedia (John Wiley & Sons, Inc. 2006) | Jan 24, 2017 | EXHIBIT | PETITIONER |
EP 0057661 | Jan 24, 2017 | EXHIBIT | PETITIONER |